Mojarrad Alireza, Omidtabrizi Arash, Ansari Astaneh Mohammadreza, Bakhtiari Elham, Shiezadeh Elham, Hassani Mohadeseh, Hosseini Seyedeh Maryam
Eye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Retina Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Int J Retina Vitreous. 2022 Sep 15;8(1):66. doi: 10.1186/s40942-022-00417-w.
The present study reports the functional and anatomical outcomes of eyes with acute retinal necrosis(ARN).
This is a retrospective case series conducted at a tertiary Eye Hospital from March 2015 to March 2020. Medical records of patients with clinical and laboratorial-Polymerase Chain Reaction (PCR)-diagnosis of ARN were reviewed. To identify factors related to the outcomes of visual acuity(VA) and retinal detachment (RD) over time, Cox proportional hazards regression modeling and survival analyses were used.
Twenty-three eyes of 23 patients (16 male, 7 female) were reviewed. Based on the PCR results, 16 cases (69.6%) had Varicella zoster virus, 3 cases (13%) had Cytomegalovirus, 1 patient (4.3%) had Herpes simplex virus associated ARN, and 1 case (4.3%) had negative PCR. The incident rate for ≥ 2-line VA gain was 0.28/eye-year (EY) (95% CI 0.21 ± 0.26) while the rate of severe vision loss was 0.09/eye-year (95% CI 0.05 ± 0.08). The RD development was observed at a rate of 0.43/eye-year (0.42 ± 0.02), which occurred in 9 eyes with a mean time of 100 days after the initial presentation of ARN. Patients' age was the only factor associated with 2-line or more gain in VA over time with a hazard ratio of 0.921 (95% CI 0.854-0.993, P = 0.032).
Generally, although being crucial, treatment is not highly effective in improvement of VA and decrease of RD development, as well as vision loss, in patients with ARN. However, treatment prevents fellow eye involvement efficiently. Younger age is associated with better response to treatment and more chance to achieve better VA.
本研究报告了急性视网膜坏死(ARN)患者眼部的功能和解剖学转归。
这是一项于2015年3月至2020年3月在一家三级眼科医院开展的回顾性病例系列研究。对临床及实验室聚合酶链反应(PCR)诊断为ARN的患者病历进行了回顾。为确定随时间推移与视力(VA)和视网膜脱离(RD)转归相关的因素,采用了Cox比例风险回归模型和生存分析。
对23例患者(16例男性,7例女性)的23只眼进行了回顾。根据PCR结果,16例(69.6%)为水痘带状疱疹病毒感染,3例(13%)为巨细胞病毒感染,1例(4.3%)为单纯疱疹病毒相关性ARN,1例(4.3%)PCR结果为阴性。视力提高≥2行的发生率为0.28/眼年(EY)(95%CI 0.21±0.26),而严重视力丧失的发生率为0.09/眼年(95%CI 0.05±0.08)。RD的发生速率为0.43/眼年(0.42±0.02),9只眼中出现RD,平均发生时间为ARN初次就诊后100天。患者年龄是随时间推移视力提高2行或更多的唯一相关因素,风险比为0.921(95%CI 0.854 - 0.993,P = 0.032)。
总体而言,尽管治疗至关重要,但在改善ARN患者的视力、降低RD发生率以及预防视力丧失方面效果并不显著。然而,治疗能有效预防健眼受累。年龄较小的患者对治疗反应更好,获得较好视力的机会更大。